Trial Profile
Safety and Preliminary Efficacy of CM082 in Combination With Paclitaxel for Treating Advanced Gastric Cancer Who Progressed on Standard First-line Treatment: a Phase 1, Dose-escalation Study
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Feb 2021
Price :
$35
*
At a glance
- Drugs Vorolanib (Primary) ; Paclitaxel
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- Sponsors AnewPharma
- 19 Feb 2019 Status changed from not yet recruiting to recruiting.
- 08 Jan 2018 Planned initiation date changed from 1 Sep 2017 to 1 Feb 2018.
- 20 Sep 2017 New trial record